The goal of this clinical trial is to assess the safety and efficacy of ViTal, a peripheral intravenous catheter with a glide-on-contact design of the plastic canula tip, in peripheral intravenous catheterization in individuals requiring intravenous therapy or blood sampling. The main question it aims to answer is: What is the first attempt success rate of the peripheral intravenous catheterization done using the study device? Participants will be asked to grade the pain they experienced when attempts were made to insert the study device into their peripheral vein.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
First attempt success rate
Timeframe: Periprocedural